Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Why Mark Carney’s Antisemitism Speech Did Not Meet the Moment 
The Law Bytes Podcast, Episode 270: Roundtable on the Bill C-22 Risks for Canadian Tech Companies Featuring VPN Services Tailscale and Windscribe 
RCMP Confirms Bill C-22 Concerns: Police Want Law to Provide Access to Encrypted Communications 
More Misinformation on Bill C-22 as the Government Struggles to Defend Its Lawful Access Plan 
The Phony Phone Book Analogy: How Liberal Cabinet Ministers and MPs are Misleading Canadians About the Privacy Risks of Bill C-22
